Tuesday, November 17, 2026

MEN'S HEALTH: Thermal Imaging of the Chest

The Science and Clinical Interpretation of Thoracic Infrared Thermology

Advancing Men’s Breast Health: Thermal Imaging, Vascular Assessment, and the Potential Role of Functional Imaging in Male Breast Cancer Evaluation

Educational analysis of actual reports interpreted by Dr. Phil Hoekstra, DABT 


Introduction: Understanding What the Human Eye Cannot See

Medical infrared thermology examines patterns, levels and behavior of heat emitted from the body’s surface. Unlike mammography, ultrasound, or MRI, which principally depict anatomical features, thermography reveals skin-surface thermal features that reflect superficial blood flow, autonomic regulation, and other physiological influences. The distinction is important: a thermal image does not directly show a tumor or identify malignant cells.

Men’s breast health deserves greater clinical and public attention. Although male breast cancer is uncommon, men may overlook breast or nipple changes or delay seeking evaluation. Two anonymized thoracic examinations interpreted by Dr. Phil Hoekstra illustrate how the laboratory measures and classifies thermal patterns across the male chest. One report describes a persistent abnormal (TH-4, see below) pattern on one side; the other describes normal (TH-1, see below) findings. These reports offer useful examples of objective patho-physiological documentation, not evidence that thermography is an effective standalone screening test for male breast cancer.

How the Technology Identifies and Reads Thermal Patterns: Infrared cameras detect infrared energy emitted by the skin and convert it into quantitative surface-temperature measurements. There is no objective color to infrared energy so calibrated color palettes are software generated enabling an intuitive association of warmer and cooler colors that will correspond to temperature ranges on each image’s scale, not to particular diseases. Both reports include anterior and lateral views, temperature reference points, and replicate imaging sets. The interpreter considers regional symmetry, focal thermal differences, the configuration and extent of superficial vascular patterns, the distribution of thermal emissions and the adaptive response of the emission levels to a physiologic challenge.

click to enlarge

A valuable distinction is between what the instrument measures and what the clinician infers. The camera measures surface infrared emission; descriptions such as hyperthermia, asymmetry, and vascular pattern characterize the resulting image. Assertions about possible underlying malignancy are interpretations that require independent clinical confirmation.

The Functional Vascular Challenge: Both reports describe two replicate sets of three high-resolution infrared images. The second set was acquired after approximately one minute of hand immersion in cool water near 53 o F (11°C). The laboratory uses this controlled stimulus to assess adaptive changes in blood flow. Cooling challenge triggers sympathetic vasoconstriction, reducing skin blood flow and altering temperature. Comparing images before and after the challenge offers a functional observation beyond a single static thermogram.

The reports describe the cool challenge as intended to distinguish normally regulated vessels from potentially unregulated hyperemia. Nevertheless, thermal responses can be affected by autonomic variation, certain medications, ambient conditions, and acquisition technique. A response pattern is not a cancer-specific test (pathognomonic).

Report A: Persistent Asymmetric Findings - The first report compares examinations from 2020, 2022, and 2023. It describes an asymmetric, moderately hyperthermic, diffuse vascular pattern in the peri-areolar and upper right pectoral region. The laboratory identified no significant thermal signs on the opposite side. Post-challenge images nevertheless showed bilaterally symmetric adaptive attenuation of emission levels after the cool challenge, indicating that the observed asymmetry and the cooling response were considered together rather than in isolation.

The right side received TH-4 and the left TH-1 across all three study dates. The interpreter described relatively small interval changes in vascular extent, caliber, and thermal emission and considered the persistence of the pattern relevant to the assessment. The report associated the TH-4 pattern with an approximate 65% risk of malignant disease. This is the laboratory’s stated risk estimate, not a confirmed diagnosis or an independently verified probability for this individual. The report recommended further objective evaluation and a comparative restudy in 90–120 days.

Report B: Symmetrical Thermal Findings: The second report found essentially symmetrical thermal patterns across both pectoral regions, without significant focal or complex vascular asymmetries or disproportionate whole-region hyperthermia. Following the cold challenge, both sides demonstrated symmetric adaptive attenuation. The laboratory assigned TH-1 to both regions and recommended annual comparative thermology.

A critical qualification appears in this report: the images did not conform to standardized protocols. That limitation matters when interpreting the strength and reproducibility of the findings. TH-1 means no qualifying thermological signs were identified under the laboratory’s criteria; it does not rule out all chances of cancer or other breast pathology.


Inside the Reports: What the Observations Add - Selected brief excerpts show the difference between measurable findings and their clinical interpretation:

Vascular configuration — Report A, p. 2 “An asymmetric, moderately hyperthermic, diffuse and vascular pattern”

Value: documents the location and character of a surface thermal asymmetry. Limitation: cannot establish its underlying cause.

Dynamic response — Report A, p. 2  “symmetric and adaptive attenuation of the emission levels”

Value: describes physiological change following a defined stimulus, adding a second dimension to static imaging.

Longitudinal comparison — Report A, p. 2 “increases of extent, caliber and relative emission levels”

Value: records changes in image characteristics over time, although evolution is not specific to malignancy.


Normal classification — Report B, p. 1  “does not indicate any thermology Signs or Criteria”

Value: illustrates how an examination without qualifying abnormalities is categorized under this laboratory’s framework.

 



The TH Scoring System: What the Numbers Mean-  The reports reference the Marseille thermological classification system, developed in the 1970s, which grades findings from TH-1 to TH-5 using defined thermal signs and criteria. These two examples substantiate the following narrower interpretation: TH-1 denotes no qualifying concerning signs, whereas TH-4 denotes multiple signs that the laboratory considers associated with increased malignancy risk. The reports do not supply a full criterion-by-criterion definition of TH-2, TH-3, or TH-5; those categories should not be reconstructed from these examples. TH scores are similar but not exactly interchangeable with BI-RADS categories.

 

Characteristic

Report A

Report B

Right pectoral TH score

TH-4

TH-1

Left pectoral TH score

TH-1

TH-1

Thermal distribution

Asymmetric right-sided pattern

Essentially symmetrical

Post-challenge response

Adaptive attenuation

Symmetric adaptive attenuation

Temporal comparison

Three examinations

No prior comparison listed

Laboratory conclusion

Concerning thermological signs

No qualifying thermological signs


Clinical Value and Important Boundaries - These examinations demonstrate several potential documentary strengths: noninvasive measurement of skin-surface temperature, comparison between anatomical sides, observation of dynamic cooling responses, and longitudinal review of thermal patterns. They also demonstrate why interpretation must be cautious. Inflammation, infection, benign vascular processes, and acquisition variability can produce variant thermal findings that are not malignant. Conversely, an apparently normal thermal study cannot exclude a lesion.

Thermography is an US Dept HHS listed adjunctive screening modality with FDA regulated equipment but not recognized as a replacement for mammography, and evidence does not establish it as an effective standalone breast cancer screening method in men. Any palpable lump, nipple discharge, nipple inversion, skin change, or other suspicious symptom warrants clinical examination and appropriate established diagnostic imaging, commonly diagnostic mammography and/or targeted ultrasound as indicated.


Conclusion: A Responsible Role in Men’s Breast Health

Dr. Hoekstra’s contrasting reports help explain how a laboratory transforms thermal measurements into descriptive findings and TH classifications. The TH-4 case shows how persistent regional asymmetry and vascular characteristics can prompt concern and further evaluation; the bilateral TH-1 case illustrates the absence of qualifying signs within the same interpretive framework. Neither classification independently diagnoses or excludes cancer.

For men’s breast health, the principal present value of these examples is educational: they encourage attention to male chest and breast changes and show how functional observations differ from structural diagnosis. Whether standardized infrared thermology can contribute clinically useful supplementary information to male breast cancer pathways remains a research question. Awareness, timely evaluation of symptoms, and evidence-based diagnostic care must remain central.



Source and Editorial Notes
Primary sources: two anonymized reports titled “Analysis of Thoracic Thermology,” interpreted by Dr. Phil Hoekstra, DABT (2023, five pages; 2026, three pages). All patient names, dates of birth, scan identifiers, and referring clinician information have been omitted. Selected short excerpts are reproduced for critical educational commentary; original thermograms and proprietary page layouts are not reproduced.

IMAGE CREDITS & SPECIAL ACKNOWLEDGMENTS

Image Credits & Courtesy

Original clinical thermographic images, medical interpretations, and supporting diagnostic materials are the intellectual property of Therma-Scan Reference Laboratory, LLC, and are presented courtesy of Dr. Phil Hoekstra and Betsey Bowers of Bet-A-Therm Thermography. Educational illustrations and graphic adaptations are included to support public understanding of infrared thermology and men's breast health. All rights to original clinical materials remain with their respective owners.

SPECIAL THANKS- We extend our sincere appreciation to Dr. Phil Hoekstra, DABT, of Therma-Scan Reference Laboratory, LLC, for his scientific expertise, clinical interpretations, and contributions to the advancement of medical infrared thermology. His work provides the clinical foundation for this educational examination of thoracic thermal imaging and its potential relevance to men's breast health. Special recognition is also extended to Betsey Bowers, Founder of Bet-A-Therm Thermography, for her commitment to expanding access to noninvasive thermal imaging services, promoting public health education, and encouraging greater awareness of emerging and complementary physiological assessment technologies.


SPECIAL RECOGNITION OF OUR SPONSORS

Our gratitude goes to Cheri Ambrose of the Male Breast Cancer Global Alliance (MBCGA) and the National Cancer Collective (NCC) for their sponsorship and support of this educational publication. Their commitment to cancer awareness, patient advocacy, survivorship, and improved quality of life helps bring greater visibility to an often-overlooked concern: men's breast health and male breast cancer. Through collaboration among medical professionals, researchers, imaging specialists, and cancer advocacy organizations, we seek to encourage informed discussion, responsible scientific inquiry, and earlier recognition of concerning breast health symptoms among men.

This publication is intended for educational purposes. Thermography is not a substitute for established breast cancer screening or diagnostic procedures. Sponsorship and acknowledgment do not constitute endorsement of thermography as a validated standalone cancer screening method.


Medical disclaimer: This paper summarizes laboratory interpretations; it does not independently validate risk percentages, test performance claims, or clinical outcomes. Infrared thermography should not replace established breast cancer screening or diagnostic imaging.





MEN'S HEALTH: Thermal Imaging of the Chest

The Science and Clinical Interpretation of Thoracic Infrared Thermology Advancing Men’s Breast Health: Thermal Imaging, Vascular Assessment,...